title: Telomere shortening and loss of self-renewal in dyskeratosis congenita induced pluripotent stem cells.
abstract: The differentiation of patient-derived induced pluripotent stem cells (iPSCs) to committed fates such as neurons, muscle and liver is a powerful approach for understanding key parameters of human development and disease. Whether undifferentiated iPSCs themselves can be used to probe disease mechanisms is uncertain. Dyskeratosis congenita is characterized by defective maintenance of blood, pulmonary tissue and epidermal tissues and is caused by mutations in genes controlling telomere homeostasis. Short telomeres, a hallmark of dyskeratosis congenita, impair tissue stem cell function in mouse models, indicating that a tissue stem cell defect may underlie the pathophysiology of dyskeratosis congenita. Here we show that even in the undifferentiated state, iPSCs from dyskeratosis congenita patients harbour the precise biochemical defects characteristic of each form of the disease and that the magnitude of the telomere maintenance defect in iPSCs correlates with clinical severity. In iPSCs from patients with heterozygous mutations in TERT, the telomerase reverse transcriptase, a 50% reduction in telomerase levels blunts the natural telomere elongation that accompanies reprogramming. In contrast, mutation of dyskerin (DKC1) in X-linked dyskeratosis congenita severely impairs telomerase activity by blocking telomerase assembly and disrupts telomere elongation during reprogramming. In iPSCs from a form of dyskeratosis congenita caused by mutations in TCAB1 (also known as WRAP53), telomerase catalytic activity is unperturbed, yet the ability of telomerase to lengthen telomeres is abrogated, because telomerase mislocalizes from Cajal bodies to nucleoli within the iPSCs. Extended culture of DKC1-mutant iPSCs leads to progressive telomere shortening and eventual loss of self-renewal, indicating that a similar process occurs in tissue stem cells in dyskeratosis congenita patients. These findings in iPSCs from dyskeratosis congenita patients reveal that undifferentiated iPSCs accurately recapitulate features of a human stem cell disease and may serve as a cell-culture-based system for the development of targeted therapeutics.
authors: Department of Medicine, Stanford University School of Medicine, Stanford, California 94305, USA.
authors: Luis F Z
authors: LF
authors: Batista
authors: Matthew F
authors: MF
authors: Pech
authors: Franklin L
authors: FL
authors: Zhong
authors: Ha Nam
authors: HN
authors: Nguyen
authors: Kathleen T
authors: KT
authors: Xie
authors: Arthur J
authors: AJ
authors: Zaug
authors: Sharon M
authors: SM
authors: Crary
authors: Jinkuk
authors: J
authors: Choi
authors: Vittorio
authors: V
authors: Sebastiano
authors: Athena
authors: A
authors: Cherry
authors: Neelam
authors: N
authors: Giri
authors: Marius
authors: M
authors: Wernig
authors: Blanche P
authors: BP
authors: Alter
authors: Thomas R
authors: TR
authors: Cech
authors: Sharon A
authors: SA
authors: Savage
authors: Renee A
authors: RA
authors: Reijo Pera
authors: Steven E
authors: SE
authors: Artandi
references: Nat Rev Mol Cell Biol. 2007 Mar;8(3):209-20
references: 17318225
references: Science. 2008 Aug 29;321(5893):1218-21
references: 18669821
references: Proc Natl Acad Sci U S A. 2005 Nov 1;102(44):15960-4
references: 16247010
references: Cell Stem Cell. 2008 Mar 6;2(3):230-40
references: 18371448
references: J Biol Chem. 2005 May 27;280(21):20449-56
references: 15792951
references: Mol Cell Biol. 2006 Mar;26(6):2146-59
references: 16507993
references: Blood. 2003 Jul 15;102(2):517-20
references: 12663456
references: Blood. 2007 Sep 1;110(5):1439-47
references: 17468339
references: Nature. 1999 Dec 2;402(6761):551-5
references: 10591218
references: Proc Natl Acad Sci U S A. 2004 Jul 20;101(29):10756-61
references: 15240872
references: Cell. 2007 Nov 30;131(5):861-72
references: 18035408
references: PLoS One. 2009 Sep 23;4(9):e7118
references: 19774082
references: Genes Dev. 2011 Jan 1;25(1):11-6
references: 21205863
references: Stem Cells. 2009 Mar;27(3):543-9
references: 19096035
references: Nature. 1998 Apr 9;392(6676):569-74
references: 9560153
references: Lancet. 1971 Oct 30;2(7731):971-2
references: 4107917
references: Nature. 2010 Mar 11;464(7286):292-6
references: 20164838
references: Cell Stem Cell. 2009 Sep 4;5(3):237-41
references: 19716359
references: Genes Dev. 2010 Mar 15;24(6):613-22
references: 20231318
references: Cell. 1989 May 19;57(4):633-43
references: 2655926
references: Nature. 2007 Feb 1;445(7127):506-10
references: 17237768
references: Nat Genet. 2004 May;36(5):447-9
references: 15098033
references: Br J Haematol. 2010 Jul;150(2):179-88
references: 20507306
references: Cell. 2009 Mar 6;136(5):964-77
references: 19269371
references: Proc Natl Acad Sci U S A. 2009 Sep 15;106(37):15768-73
references: 19720998
references: Mol Biol Cell. 2008 Sep;19(9):3793-800
references: 18562689
references: Science. 2009 Jan 30;323(5914):644-8
references: 19179534
references: Genes Dev. 2006 Oct 15;20(20):2848-58
references: 17015423
references: J Clin Invest. 2010 Sep;120(9):3127-36
references: 20739751
references: EMBO J. 2006 Feb 8;25(3):565-74
references: 16424902
references: Mol Cell. 2009 Apr 10;34(1):47-57
references: 19285445
references: Cell Stem Cell. 2009 Feb 6;4(2):141-54
references: 19200803
references: Br J Haematol. 2009 Apr;145(2):164-72
references: 19208095
references: J Biol Chem. 2005 Feb 25;280(8):6257-60
references: 15615706
references: Cell. 2008 Mar 21;132(6):945-57
references: 18358808
references: FEBS Lett. 2010 Sep 10;584(17):3831-8
references: 20493861
references: Nature. 2011 Apr 14;472(7342):221-5
references: 21346760